Susan Pinker
Abstract
Quebec has launched a mass vaccination program against meningococcal disease that will cost at least $100 million. Under the campaign, 1.7 million Quebecers aged 2 months to 20 years are being offered a new vaccine that provides longer protection against group C meningococcal infection. The
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Quebec has launched a mass vaccination program against meningococcal disease that will cost at least $100 million. Under the campaign, 1.7 million Quebecers aged 2 months to 20 years are being offered a new vaccine that provides longer protection against group C meningococcal infection. The
Key concepts: Meningococcal disease, Mass vaccination, Meningococcal Infections, Vaccination, Meningococcal vaccine, Medicine, Neisseria meningitidis, Virology